The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity
Subscribe To Our Newsletter & Stay Updated
